These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 8096393

  • 1. Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia.
    Pecknold JC.
    J Psychiatry Neurosci; 1993 Mar; 18(2):82-4. PubMed ID: 8096393
    [Abstract] [Full Text] [Related]

  • 2. Benzodiazepine augmentation of neuroleptics in treatment-resistant schizophrenia.
    Wolkowitz OM, Turetsky N, Reus VI, Hargreaves WA.
    Psychopharmacol Bull; 1992 Mar; 28(3):291-5. PubMed ID: 1362277
    [Abstract] [Full Text] [Related]

  • 3. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia.
    Wolkowitz OM, Pickar D, Doran AR, Breier A, Tarell J, Paul SM.
    Am J Psychiatry; 1986 Jan; 143(1):85-7. PubMed ID: 2867690
    [Abstract] [Full Text] [Related]

  • 4. Antipsychotic medication: clinical guidelines for maintenance therapy.
    Johnson DA.
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):6-15. PubMed ID: 2859281
    [Abstract] [Full Text] [Related]

  • 5. Benzodiazepine augmentation of neuroleptic treatment in patients with schizophrenia.
    Pato CN, Wolkowitz OM, Rapaport M, Schulz SC, Pickar D.
    Psychopharmacol Bull; 1989 May; 25(2):263-6. PubMed ID: 2574897
    [No Abstract] [Full Text] [Related]

  • 6. [Schizophrenia combination therapy with neuroleptics and benzodiazepines].
    Ruzikowska A.
    Psychiatr Pol; 1996 May; 30(1):55-64. PubMed ID: 8722239
    [Abstract] [Full Text] [Related]

  • 7. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV, Brown WA, Laughren TP.
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [Abstract] [Full Text] [Related]

  • 8. Benzodiazepines (BZ) for the management of psychosis.
    Easton MS, Janicak PG.
    Psychiatr Med; 1991 Apr; 9(1):25-36. PubMed ID: 1673257
    [Abstract] [Full Text] [Related]

  • 9. Concurrent psychotropic medication has no negative influence on the outcome of electroconvulsive therapy.
    O'Brien PD, Berrios GE.
    Encephale; 1993 Apr; 19(4):347-9. PubMed ID: 7903929
    [Abstract] [Full Text] [Related]

  • 10. [Resistant schizophrenia: what chemotherapy?].
    Vanelle JM.
    Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
    [No Abstract] [Full Text] [Related]

  • 11. Effect of the benzodiazepine derivative estazolam in schizophrenia.
    Astrup C, Vatten L.
    Biol Psychiatry; 1984 Jan; 19(1):85-8. PubMed ID: 6142731
    [No Abstract] [Full Text] [Related]

  • 12. Benzodiazepines in the treatment of schizophrenia: an updated survey.
    Lingjaerde O.
    Acta Psychiatr Scand; 1991 Nov; 84(5):453-9. PubMed ID: 1685616
    [Abstract] [Full Text] [Related]

  • 13. [Depot neuroleptics in social psychiatric practice].
    Pruss U, Rose HK, Zechner A.
    Psychiatr Prax; 1984 Jul; 11(4):101-8. PubMed ID: 6148764
    [Abstract] [Full Text] [Related]

  • 14. Combined alprazolam and neuroleptic drug in treating schizophrenia.
    Bacher NM, Lewis HA, Field PB.
    Am J Psychiatry; 1986 Oct; 143(10):1311-3. PubMed ID: 2876649
    [No Abstract] [Full Text] [Related]

  • 15. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA, Olfson M.
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [Abstract] [Full Text] [Related]

  • 16. Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia.
    Barbee JG, Mancuso DM, Freed CR, Todorov AA.
    Am J Psychiatry; 1992 Apr; 149(4):506-10. PubMed ID: 1348161
    [Abstract] [Full Text] [Related]

  • 17. Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label study.
    Csernansky JG, Lombrozo L, Gulevich GD, Hollister LE.
    J Clin Psychopharmacol; 1984 Dec; 4(6):349-52. PubMed ID: 6150950
    [Abstract] [Full Text] [Related]

  • 18. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
    Kim JH, Kim SY, Ahn YM, Kim YS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):301-5. PubMed ID: 16309807
    [Abstract] [Full Text] [Related]

  • 19. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT, Rada RT.
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [Abstract] [Full Text] [Related]

  • 20. Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates.
    Douyon R, Angrist B, Peselow E, Cooper T, Rotrosen J.
    Am J Psychiatry; 1989 Feb; 146(2):231-4. PubMed ID: 2563211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.